Table 3.
Baseline (T0) | Two months follow-up (T1) | Six months follow-up (T2) | ||||
---|---|---|---|---|---|---|
(n.) | Study subjects (33) | Control group (36) | Study subjects (33) | Control group (36) | Study subjects (19) | Control group (18) |
Cervical spine | 3.5±2.8 | 4.3±3.1 | 2.4±2.4 | 3.5±2.7 | 2.8±2.1 | 3.8±2.9 |
Shoulders | 3.5±2.6 | 4.3±3.1 | 2.6±2.6 | 3.5±2.9 | 2.7±2.2 | 3.6±2.9 |
Upper limbs | 2.1±2.7 | 2.3±3.1 | 1.1±2.3 | 1.8±2.5 | 1.5±2.2 | 2.7±3.3 |
Dorsal spine | 3.2±3 | 3.6±3.1 | 1.9±2.9* | 3.1±2.9** | 2.2±2.4 | 2.7±2.8 |
Lumbar spine | 4.9±3.2 | 4.8±3.2 | 2.9±2.9* | 3.7±3.1 | 2.5±2.9 | 4.3±2.7*** |
Lower limbs | 2.5±3.4 | 3.1±3.3 | 2±3.1 | 2.1±3.1 | 1.8±3 | 2.4±3.4 |
Overall pain | 19.5±11.2 | 22.6±13.3 | 12.9±11* | 17.7±11.6** | 13.4±11.5^ | 19.4±11.8 |
Headache (%) | 27(81.8%) | 20(57.1%) | 21(58.3%) * | 17(54.8%) | 13(72.2%) | 14(73.8%) |
Body awareness | 6.6±2 | 6±2.3 | 7.5±1.6* | 6.4±2.2 | 7.6±1.2^ | 6.7±1.9 |
* p<0.05 between T0 and T1 in cases; ** p<0.05 between case and controls at T1; *** p<0.05 between cases at T2 and controls at T2; ^p<0.05 between cases T0 and T2